Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Deutsches Arzteblatt International|March 26, 2014
Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicalsNicolas Hohmann, Gerd Mikus, David Czock
Journal of Clinical Pharmacology|July 14, 2016
No Increased Risk of Ketoconazole Toxicity in Drug-Drug Interaction StudiesNoémi Outeiro, Nicolas Hohmann, Gerd Mikus
Pharmacogenomics|June 23, 2011
Pharmacogenomics of the triazole antifungal agent voriconazoleGerd Mikus, Ina Maria Scholz, Johanna Weiss
Clinical Pharmacokinetics|May 1, 2015
Use of microdose phenotyping to individualise dosing of patientsNicolas Hohmann, Walter E Haefeli, Gerd Mikus
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
CYP3A activity: towards dose adaptation to the individualNicolas Hohmann, Walter E Haefeli, Gerd Mikus
Current Pharmaceutical Design|September 2, 2015
Clinical Pharmacology of Frequently Used Intravenous Drugs During Bariatric Surgery in AdolescentsJanelle D Vaughns, Victoria C Ziesenitz, John N van den Anker
Palliative Medicine|April 27, 2019
Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3AMarcus Geist, Hubert Bardenheuer, Juergen Burhenne, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2020
Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activitySabrina T Wiebe, Andreas D Meid, Gerd Mikus
Pageof 20